Back to search

Article

BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial

2024-05-04

Abstract excerpt

<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> Genetic testing to identify germline high-risk pathogenic variants in breast cancer susceptibility genes is an important step in the breast cancer diagnostic pathway. To expand capacity and reduce turnaround time, testing is increasingly offered within ‘mainstream’ oncology services, rather than via referral to clinical genetics. However, mainstream capacity is also stretched,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bdde3b0c-d770-51db-b8f1-cf8aaf16e56d
DOI
10.1101/2024.05.03.24306669
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trialDOI 10.1101/2024.05.03.24306669
Select a neighboring publication to make it the new centre.